NRTSF OTC
Nobilis Health Corp.
1W: +0.0%
1M: +0.0%
3M: -90.0%
1Y: -100.0%
3Y: -100.0%
5Y: -100.0%
$0.00
Last traded 2025-12-23 — delisted
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$300M
+4.9% ▲
5Y CAGR: +70.3%
Gross Profit
$187M
+6.3% ▲
5Y CAGR: +66.4%
Operating Income
$22M
+122.2% ▲
5Y CAGR: +19.2%
Net Income
$4M
-41.1% ▼
5Y CAGR: +25.9%
EPS (Diluted)
$0.05
-37.5% ▼
5Y CAGR: +10.8%
EBITDA
$34M
+78.5% ▲
5Y CAGR: +41.2%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2013 | FY2014 | FY2015 | FY2016 | FY2017 |
|---|---|---|---|---|---|
| Revenue | $31M | $84M | $229M | $286M | $300M |
| YoY Growth | +49.0% | +169.9% | +172.8% | +24.7% | +4.9% |
| Cost of Revenue | $10M | $23M | $78M | $110M | $113M |
| Gross Profit | $21M | $61M | $151M | $176M | $187M |
| Gross Margin | 68.7% | 72.4% | 65.9% | 61.6% | 62.4% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $16M | $38M | $111M | $157M | $151M |
| Operating Expenses | $17M | $40M | $116M | $166M | $162M |
| Operating Income | $10M | $21M | $32M | $10M | $22M |
| Operating Margin | 32.4% | 24.8% | 13.8% | 3.5% | 7.4% |
| Interest Expense | $0 | $0 | $2M | $4M | $6M |
| Income Before Tax | $7M | $20M | $41M | $12M | $23M |
| Tax Expense | $3M | $13M | -$23M | $4M | $13M |
| Net Income | $1M | $7M | $51M | $6M | $4M |
| Net Margin | 4.5% | 8.0% | 22.2% | 2.3% | 1.3% |
| EPS (Diluted) | $0.04 | $0.14 | $0.68 | $0.08 | $0.05 |
| EBITDA | $5M | $22M | $36M | $19M | $34M |
| Shares Outstanding | 38M | 49M | 75M | 78M | 78M |